Contact
If you need media that scales, we'd like to help. Get in touch with us using the form below.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
If you need media that scales, we'd like to help. Get in touch with us using the form below.
MediOP™ is Multus’ AI-enabled media design platform. It powers every one of our off-the-shelf and custom formulations by turning media development into a data-rich engineering discipline to deliver faster cycles, tighter batch-to-batch consistency, clearer regulatory pathways, and media brings scale-up within reach.
By combining advances in AI and robotics with our deep biological expertise, our platform designs custom media tailored to the exact needs of each cell type and industry application. This fusion of disciplines allows us to move beyond one-size-fits-all recipes and create formulations that accelerate breakthroughs in biopharma, biomanufacturing, and beyond, giving our customers a competitive edge at every milestone.
Most media campaigns still tweak old recipes and hope for incremental gains. MediOP™ starts de novo, with cells, objectives, and constraints in mind. The platform couples high-throughput automation with adaptive, Bayesian-inspired experimental design to explore and learn from thousands of conditions in parallel.
It combines science, engineering, robotics, and AI, allowing us to test thousands of conditions in parallel, generate richer data, and design media tailored to the exact needs of each cell type. This interdisciplinary approach turns media development into a true engineering discipline - faster, smarter, and more reliable than traditional approaches.
We apply the depth of our existing data to inform and refine every next experiment. This feedback loop is what makes MediOP™ both novel and effective: the more it runs, the smarter and more targeted it becomes, delivering better media that bridges scientific discovery to real-world impact.
We like to think of the formulation space as a rugged terrain with many peaks and valleys. MediOP™ is an explorer: it scouts widely at first, learns from what it finds, and then climbs the most promising peaks - balancing performance, cost, and compliance to reach the most rewarding summits for any specific application.
Because MediOP™ spans multiple fields, we've pulled together frequently asked questions to help clarify how it works, what makes it unique, and why it matters for your success:
MediOP™ combines adaptive, Bayesian-inspired experimental design with more throughput and richer readouts. Instead of testing a few combinations of ingredients/conditions, it navigates a complex landscape and learns where to look next. This means you get optimized formulations faster while reducing the risk of late-stage failures that can derail timelines and budgets.
By structuring the search and letting the data drive decisions, MediOP™ reduces late-stage failure risk, shortens time to clinic or scale, and lowers COGS - benefits that are difficult to replicate with ad-hoc experiments and inherited recipes. Our customers typically see accelerated development timelines and improved unit economics that strengthen their competitive position.
Yes. MediOP™ is cell-agnostic and goal-driven. We've successfully onboarded cell lines such as HEK, CHO, Jurkat, and more across diverse applications. Every project starts with a short compatibility phase to confirm objective definitions and constraints. Then we begin designing media starting from your cells and requirements, rather than adapting a template - ensuring optimal performance for your specific needs.
Automation allows us to run thousands of parallel experiments with high reproducibility, while our AI proposes the next most informative experiments. But interpretation, biological insight, and final decision-making remain human-led by our expert scientists and data analysts who set objectives and constraints, interpret biological trade-offs (e.g., growth vs. phenotype vs. cost), and make final design decisions.
In short: automation generates clean, comparable data at scale; humans turn that data into formulations you can trust and implement with confidence.
None. We can begin de novo and learn directly from your cells. If you have prior characterization data, we'll use it to shrink the initial search space and accelerate early decisions - but it's optional. This flexibility means you can access our AI-enabled platform regardless of your current data maturity.
Most of our programs lock an optimized formulation in 6–9 months, delivered through three design campaigns. Each campaign provides interim candidates, data, and clear interpretation that feed the next cycle, ensuring you have actionable insights throughout the process. Timing reflects factors like cell onboarding and objective complexity, but our structured approach minimizes uncertainty and keeps projects on track.
MediOP™ transforms media design from guesswork into a controllable lever for speed, quality, and scale. Better media is the bridge from scientific discovery to real-world impact, and Multus has the platform to power the breakthroughs that matter for your success.
Talk to our media specialists about your objectives and constraints today, and we'll scope a MediOP™ campaign that gets you to an optimized formulation with the results you need.
Sign up for email updates:
